Demyelinating Diseases 02

Topic: Adult

Created on Tuesday, November 4 2008 by jdmiles

Last modified on Tuesday, November 4 2008.

 
        A) HLA DR2
 
        B) PF81
 
        C) Sclerosin
 
        D) GVF6
 
        E) MX9
 

 

	= Go back to the top of the page.
	= Reload a different version of this question ().
	= Load a random question from the database.
	= Use this question as a template to create a totally NEW question.
	= Enter detailed rating for this question!
	= How users like you have rated this question.

This question was created on November 04, 2008 by jdmiles.
This question was last modified on November 04, 2008.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ANSWERS AND EXPLANATIONS

---

A) HLA DR2

This answer is correct.

The human leukocyte antigen (HLA) DR2 allele has been shown to be associated with an increased risk in developing MS. HLA DR2 is also known as HLA DRB1*1501-DQB1*0602.  (See References)

Please log in if you want to rate questions.

 

 

 

 

 

 

 

 

 

---

B) PF81

This answer is incorrect.

The human leukocyte antigen (HLA) DR2 allele has been shown to be associated with an increased risk in developing MS.  (See References)

Please log in if you want to rate questions.

 

 

 

 

 

 

 

 

 

---

C) Sclerosin

This answer is incorrect.

The human leukocyte antigen (HLA) DR2 allele has been shown to be associated with an increased risk in developing MS.  (See References)

Please log in if you want to rate questions.

 

 

 

 

 

 

 

 

 

---

D) GVF6

This answer is incorrect.

The human leukocyte antigen (HLA) DR2 allele has been shown to be associated with an increased risk in developing MS.  (See References)

Please log in if you want to rate questions.

 

 

 

 

 

 

 

 

 

---

E) MX9

This answer is incorrect.

The human leukocyte antigen (HLA) DR2 allele has been shown to be associated with an increased risk in developing MS.  (See References)

Please log in if you want to rate questions.

 

 

 

 

References:

1. Kalman, B., and Lublin, F.D. (1999). "The genetics of multiple sclerosis. A review." Biomed Pharmacother, 53(8) 358-70. (PMID:10554670)
2. Online Mendelian Inheritance in Man Database (OMIM:126200).	Link to OMIM DATABASE
3. Barcellos, L.F., Oksenberg, J.R., Begovich, A.B., Martin, E.R., Schmidt, S., Vittinghoff, E., Goodin, D.S., Pelletier, D., Lincoln, R.R., Bucher, P., Swerdlin, A., Pericak-Vance, M.A., Haines, J.L., and Hauser, S.L. (2003). "HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course." Am J Hum Genet, 72(3) 710-6. (PMID:12557126)
4. Zipp, F., Weber, F., Huber, S., Sotgiu, S., Czlonkowska, A., Holler, E., Albert, E., Weiss, E.H., Wekerle, H., and Hohlfeld, R. (1995). "Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells." Ann Neurol, 38(5) 723-30. (PMID:7486863)

Please log in if you want to rate questions.

 

FrontalCortex.com -- Neurology Review Questions -- Neurology Boards -- Board Review -- Residency Inservice Training Exam -- RITE Exam Review
adult
Demyelinating Diseases 02
Question ID: 110408077
Question written by J. Douglas Miles, (C) 2006-2009, all rights reserved.
Created: 11/04/2008
Modified: 11/04/2008
Estimated Permutations: 25200